• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 1, 2024
Distillery Therapeutics

PIK3CG-degrading PROTAC for AML

Read More
BioCentury | May 2, 2024
Data Byte

Four PDUFA dates coming in May

BMS awaits decisions on two new indications for Breyanzi; therapies from Ascendis, Dynavax also up for approvals
Read More
BioCentury | May 10, 2023
Discovery & Translation

Integrated’s AI platform to discover senolytic compounds; plus Editas’ transgene knock-in method and more

BioCentury’s roundup of translational news
Read More
BioCentury | Feb 4, 2023
Market Access

Rare diseases, MNCs grow presence on China’s NRDL

Even with big price reductions, China’s national reimbursement list is a lure for drug developers around the globe
Read More
BioCentury | Jan 11, 2023
Finance

Facing Humira cliff, AbbVie sees return to ‘strong growth’ by 2025

CEO Gonzalez predicts immunology drugs Skyrizi and Rinvoq will surpass Humira’s peak sales in 2027, says deals could augment post-2030 picture
Read More
BioCentury | Aug 5, 2022
Discovery & Translation

Daley lab’s iPSC-derived T cell differentiation method; plus Harbour’s CTLA-4 antibody and more

BioCentury’s roundup of translational news
Read More
BioCentury | Apr 27, 2022
Deals

Pfizer invests $25M in Zentalis, will advise on development of WEE1 program

Pharma lends Zentalis clinical expertise on a high-priority program, to which the biotech retains full ownership
Read More
BioCentury | Feb 10, 2022
Discovery & Translation

Translational trendspotting: a Distillery dive into neurology

Highlights include a new approach to the amyloid hypothesis, white space strategies for stroke and gene therapies
Read More
BioCentury | Dec 3, 2021
Discovery & Translation

Mapping the plasma proteome to identify drug targets; plus GSK-Vir, Codiak and more

BioCentury’s roundup of translational news
Read More
BioCentury | Aug 23, 2021
Deals

Pfizer sees potential best-in-class CD47s in $2.3B Trillium takeout

In high-premium deal, Pfizer gains fusion proteins for blood cancers
Read More
Items per page:
1 - 10 of 228